Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Anabolic steroid users may face higher risk of severe COVID-19.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 can cause significant hair loss.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 infection can significantly cause temporary hair loss.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 can cause skin problems in children.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.